9397-2677 Québec inc.
$30,000.00 CAD
≈ 5 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- October 9, 2023 – July 1, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q3-1010568
Published purpose
This project aims to develop an ex vivo platform for the development of cancer immunotherapies and the discovery of predictive biomarkers. The project includes the development of protocols for 1) preserving/transporting human tumor samples and 2) maintaining the ex vivo viability of a new type of cancer.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions